Dr. Sridevi Rajeeve, MD
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $4,671 | 2 | 79.9% |
| Food and Beverage | $1,046 | 16 | 17.9% |
| Education | $131.98 | 2 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Global Services, LLC | $4,671 | 2 | $0 (2024) |
| Seagen Inc. | $381.98 | 4 | $0 (2023) |
| PFIZER INC. | $160.76 | 3 | $0 (2024) |
| GENZYME CORPORATION | $140.51 | 2 | $0 (2024) |
| Current Health Inc. | $139.17 | 2 | $0 (2024) |
| Amgen Inc. | $122.11 | 1 | $0 (2022) |
| Janssen Biotech, Inc. | $106.32 | 2 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $66.72 | 3 | $0 (2024) |
| AstraZeneca UK Limited | $60.00 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,323 | 14 | Janssen Global Services, LLC ($4,671) |
| 2023 | $153.66 | 3 | Seagen Inc. ($131.98) |
| 2022 | $122.11 | 1 | Amgen Inc. ($122.11) |
| 2021 | $250.00 | 2 | Seagen Inc. ($250.00) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | Janssen Global Services, LLC | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 12/08/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $67.29 | General |
| Category: Oncology | ||||||
| 12/07/2024 | AstraZeneca UK Limited | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 11/12/2024 | Janssen Global Services, LLC | TECVAYLI (Biological) | Consulting Fee | Cash or cash equivalent | $3,321.00 | General |
| Category: Oncology | ||||||
| 10/01/2024 | Current Health Inc. | — | Food and Beverage | Cash or cash equivalent | $48.28 | General |
| 09/28/2024 | Janssen Biotech, Inc. | CARVYKTI (Drug) | Food and Beverage | In-kind items and services | $39.03 | General |
| Category: Oncology | ||||||
| 09/26/2024 | PFIZER INC. | ELREXFIO (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ONCOLOGY | ||||||
| 08/03/2024 | Current Health Inc. | — | Food and Beverage | Cash or cash equivalent | $90.89 | General |
| 07/17/2024 | Janssen Scientific Affairs, LLC | TECVAYLI (Biological), TALVEY, DARZALEX | Food and Beverage | In-kind items and services | $29.76 | General |
| Category: Oncology | ||||||
| 07/16/2024 | Janssen Scientific Affairs, LLC | DARZALEX (Biological), TALVEY, TECVAYLI | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Oncology | ||||||
| 06/02/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $118.35 | General |
| Category: ONCOLOGY | ||||||
| 05/13/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $118.17 | General |
| Category: Oncology | ||||||
| 01/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Oncology | ||||||
| 09/29/2023 | Janssen Scientific Affairs, LLC | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Oncology | ||||||
| 06/06/2023 | Seagen Inc. | — | Education | In-kind items and services | $61.99 | General |
| 02/07/2023 | Seagen Inc. | — | Education | In-kind items and services | $69.99 | General |
| 04/07/2022 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $122.11 | General |
| Category: Oncology | ||||||
| 11/03/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 10/21/2021 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 15 | 61 | $31,720 | $6,468 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 61 | $31,720 | $6,468 | 20.4% |
About Dr. Sridevi Rajeeve, MD
Dr. Sridevi Rajeeve, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2017. The National Provider Identifier (NPI) number assigned to this provider is 1154843944.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sridevi Rajeeve, MD has received a total of $5,849 in payments from pharmaceutical and medical device companies, with $5,323 received in 2024. These payments were reported across 20 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($4,671).
As a Medicare-enrolled provider, Rajeeve has provided services to 15 Medicare beneficiaries, totaling 61 services with total Medicare billing of $6,468. Data is available for 1 year (2023–2023), covering 1 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location New York, NY
- Active Since 07/13/2017
- Last Updated 09/19/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1154843944
Products in Payments
- TECVAYLI (Biological) $4,701
- ADCETRIS (Biological) $250.00
- ELREXFIO (Drug) $160.76
- SARCLISA (Biological) $140.51
- LUMAKRAS (Drug) $122.11
- DARZALEX (Biological) $104.25
- CARVYKTI (Drug) $39.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in New York
Dr. Saakshi Khattri, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1.7M
Cheguevara Afaneh, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $1.5M
John Allan, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $550,557
Jose Scher, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $496,980
Dr. Anthony Rossi, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $442,377
Anuradha Lala-Trindade
Student in an Organized Health Care Education/Training Program — Payments: $284,341